Concepedia
Statistics
Publications
21
Citations
1.5K
H-Index
18
Active since
1999
Affiliations
Pearl River Community College(Current)
Pfizer (United States)
Dalian Institute of Chemical Physics
Dalian National Laboratory for Clean Energy
Chinese Academy of Sciences
Xingzhi Tan is an author at Pearl River Community College specializing in medicine, pharmacology, and cancer pharmacology.
Publications per year
1999–2023
Tumor Cells Chronically Treated with a Trastuzumab–Maytansinoid Antibody–Drug Conjugate Develop Varied Resistance Mechanisms but Respond to Alternate Treatments
Frank Loganzo, Xingzhi Tan, Matthew Sung et al. · Molecular Cancer Therapeutics · 2015 · 270 citations
Medicine, Immunology, Oncology +17
Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1)
Matthew Sung, Xingzhi Tan, Bingwen Lu et al. · Molecular Cancer Therapeutics · 2017 · 208 citations
Medicine, Oncology, Pharmacology +17
Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of β-tubulin (Asp26Glu) and less stable microtubules
Malathi Hari, Frank Loganzo, Tami Annable et al. · Molecular Cancer Therapeutics · 2006 · 147 citations
HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.
Frank Loganzo, Carolyn Discafani, Tami Annable et al. · PubMed · 2003 · 137 citations
Medicine, Medicinal Chemistry, Pharmacology +17
Comparison of the mutagenic properties of 8-oxo-7,8-dihydro-2′-deoxyadenosine and 8-oxo-7,8-dihydro-2′-deoxyguanosine DNA lesions in mammalian cells
Xingzhi Tan, Arthur P. Grollman, Shinya Shibutani · Carcinogenesis · 1999 · 118 citations
Life Sciences, Genetics, Molecular Biology +15
1–5 of 21